|
|
|
Volumn 16, Issue 3, 2003, Pages 177-182
|
|
Is There a Best Strategy for Drug Discovery?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOZAPINE;
DOPAMINE;
SEROTONIN;
ANIMAL MODEL;
BIOINFORMATICS;
BIOTECHNOLOGY;
COMBINATORIAL CHEMISTRY;
COMPUTER ANALYSIS;
CONFERENCE PAPER;
DRUG DEVELOPMENT;
DRUG DISCOVERY;
DRUG INDUSTRY;
DRUG SAFETY;
DRUG SCREENING;
DRUG TARGETING;
GENETICS;
HIGH THROUGHPUT SCREENING;
HISTORY;
PHARMACOECONOMICS;
PHARMACOGENETICS;
PHARMACOGENOMICS;
PHYLOGENY;
TIME;
TOXICITY TESTING;
TOXICOGENETICS;
TOXICOGENOMICS;
TOXICOLOGY;
ANIMAL;
DRUG DESIGN;
EXPERIMENTAL THERAPY;
HUMAN;
METHODOLOGY;
PHARMACEUTICS;
QUANTITATIVE STRUCTURE ACTIVITY RELATION;
ANIMALS;
COMBINATORIAL CHEMISTRY TECHNIQUES;
DRUG DESIGN;
DRUG INDUSTRY;
HUMANS;
PHARMACOGENETICS;
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;
TECHNOLOGY, PHARMACEUTICAL;
THERAPIES, INVESTIGATIONAL;
|
|
EID: 0141544947
PISSN: 02140934
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (8)
|
|
References (0)
|
